Related Experiment Videos
[Myocardial revascularization in acute coronary syndrome without ST-segment elevation]
1Service des maladies du coeur et des vaisseaux CHU Côte de Nacre 14033 Caen. hamon-m@chu-caen.fr
La Revue Du Praticien
|May 17, 2003
Summary
An early invasive strategy is recommended for acute coronary syndrome without ST elevation, often involving angiocoronarography and stent implantation. Glycoprotein IIb/IIIa inhibitors offer benefits for high-risk patients during treatment and intervention.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Context:
- Management of acute coronary syndrome (ACS) without persistent ST segment elevation.
- Current guidelines recommend an early invasive approach.
Purpose:
- To outline the benefits of an early invasive strategy in ACS.
- To discuss treatment modalities including angiocoronarography, stent implantation, and pharmacotherapy.
Summary:
- Early invasive management with angiocoronarography identifies culprit lesions for potential stent implantation.
- Glycoprotein IIb/IIIa receptor inhibition is advised for high-risk ACS patients, enhancing medical treatment and percutaneous coronary intervention.
- Coronary artery bypass grafting is typically reserved for complex cases like left main or three-vessel disease, particularly with left ventricular dysfunction or diabetes.
Impact:
- Optimizes treatment decisions for ACS patients.
- Improves patient outcomes through timely and targeted interventions.
- Provides a framework for managing complex coronary artery disease.